IndiaOne Finance - Company Dashboard

Governance Classic Home

Bafna Pharmaceuticals LtdPharmaceuticalsINE878I01022Standalone₹317.20+6.20 (+1.99%)Jun-26

Valuation

Market Cap₹750.38 Cr

TTM PE96.41x

Forward PE120.76x

PEG-3.23

Book Value₹40.64

P/B7.80x

TTM EPS₹3.29

Fwd EPS₹2.63

TTM Revenue₹142.58 Cr

TTM PAT₹7.80 Cr

TTM EBITDA₹11.76 Cr

TTM EBIT₹5.28 Cr

Last Qtr PAT₹0.08 Cr

Last Qtr EBITDA₹0.88 Cr

Last Qtr EBIT₹-0.90 Cr

Profitability

ROE8.11%

ROCE9.00%

TTM NPM5.47%

TTM EBITDA %8.25%

Curr OPM0.28%

Last OPM6.25%

Curr NPM—

Last NPM—

Curr EPS₹0.03

Last EPS₹1.16

Balance sheet

Equity₹23.66 Cr

Reserve₹72.49 Cr

Total Debt₹37.43 Cr

D/E0.39x

Interest %1175.00%

Curr Interest₹0.94 Cr

Price / range

Close₹317.20

vs 52W High-0.41%

vs 52W Low+233.89%

MA50—

MA200—

Returns

1D+1.99%

1W+5.22%

1M+28.16%

3M+105.49%

6M+179.23%

1Y+142.41%

2Y+304.08%

3Y+253.43%

5Y+3150.00%

Diwali+110.34%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	26.58-23.2%	42.24	38.29	35.47	34.62	150.62
Other Income	1.91	1.76	1.22	1.18	0.60	4.76
Total Income	28.49-19.1%	44	39.51	36.65	35.22	155.37
Interest	0.94	1.03	0.86	0.86	0.91	3.66
Expenditure	-28.42+10.7%	-41.38	-37.67	-33.52	-31.83	-144.40
PBDT	0	0	0	0	0	0
EBITDA	0.88-82.6%	3.55	3.05	4.28	5.07	15.95
Depreciation	-1.78	-1.66	-1.57	-1.47	-1.37	-6.07
EBIT	-0.90-124.3%	1.89	1.48	2.81	3.70	9.88
PBT	0.08-97.6%	2.62	1.84	3.13	3.39	10.97
Tax	0	0.13	0	0	0	0.13
Equity	23.66	23.66	0	0	23.66	23.66
OPM	0.28	5.95	4.80	8.81	9.63	7.06
Net Profit	0.08-97.6%	2.75	1.84	3.13	3.39	11.10
NPM	0.28	6.25	4.80	8.81	9.63	7.14
EPS	0.03-97.9%	1.16	0.78	1.32	1.43	4.69

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	150.62+3.3%	145.86-4.3%	152.47+32.2%	115.35+35.5%	85.14+19.5%	71.22
Other Income	4.76	2.74	3.52	3.27	2.10	0.75
Total Income	155.37+4.6%	148.60-4.7%	155.99+31.5%	118.62+36.0%	87.24+21.2%	71.97
Expenditure	-144.40-1.5%	-142.30+4.3%	-148.64-38.9%	-107.01-33.9%	-79.94-20.9%	-66.14
Interest	-3.66	-2.73	-2.29	-2.04	-0.79	-0.74
PBDT	0	0	0	0	0	0
EBITDA	15.95+42.7%	11.18+0.5%	11.12-29.2%	15.71+36.8%	11.48+11.5%	10.30
Depreciation	-6.07	-4.89	-5	-5.33	-5.49	-4.48
EBIT	9.88+57.1%	6.29+2.8%	6.12-41.0%	10.38+73.3%	5.99+2.9%	5.82
PBT	10.97+164.3%	4.15-43.5%	7.35-36.7%	11.62+125.6%	5.15-11.7%	5.83
Tax	0.13	0	0	-0.28	0	0
Equity	23.66	23.66	0	0	0	0
OPM (%)	7.06	2.79	5.00	10.00	6.00	8.00
Net Profit	11.10+167.5%	4.15-43.5%	7.35-35.2%	11.34+120.2%	5.15-11.7%	5.83
NPM (%)	7.14	2.79	5.00	10.00	6.00	8.00
EPS (Rs)	4.69+166.5%	1.76-43.4%	3.11-36.0%	4.86+124.0%	2.17-11.8%	2.46
CEPS	4.69	1.76	3.11	4.86	2.17	2.46

Metric	Mar-20	Dec-19	Sep-19	Jun-19	FY25-26
Revenue	13.13	10.93	11.57	6.85	150.62
Other Income	-0.67	0.03	0.59	0.30	4.76
Total Income	12.46	10.96	12.16	7.15	155.37
Interest	0.03	0.10	0.05	0.13	3.66
Expenditure	-9.44	-11.61	-12.71	-10.86	-144.40
PBDT	0	0	0	0	0
EBITDA	4.25	0.42	-0.37	-2.86	15.95
Depreciation	-0.53	-1	-0.72	-1.02	-6.07
EBIT	3.72	-0.58	-1.09	-3.88	9.88
PBT	2.18	-22.36	-0.55	-3.71	10.97
Tax	-1.58	0.04	-0.04	1.58	0.13
Equity	0	0	0	0	23.66
OPM	17.51	-204.09	-4.53	-51.88	7.06
Net Profit	0.32	-22.33	-0.59	-2.13	11.10
NPM	2.55	-203.77	-4.85	-29.76	7.14
EPS	0.20	-94.39	-0.50	-0.90	4.69

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 19-20	FY 18-19
Revenue	150.62+3.3%	145.86	42.47-2.1%	43.36
Other Income	4.76	2.74	0.26	0.65
Total Income	155.37+4.6%	148.60	42.73-2.9%	44.01
Expenditure	-144.40-1.5%	-142.30	-44.61+28.4%	-62.31
Interest	-3.66	-2.73	-0.10	-2.13
PBDT	0	0	0	0
EBITDA	15.95+42.7%	11.18	1.23+109.2%	-13.34
Depreciation	-6.07	-4.89	-3.27	-3.48
EBIT	9.88+57.1%	6.29	-2.04+87.9%	-16.82
PBT	10.97+164.3%	4.15	-24.44-41.4%	-17.28
Tax	0.13	0	0	-1.07
Equity	23.66	23.66	0	0
OPM (%)	7.06	2.79	-57.21	-39.27
Net Profit	11.10+167.5%	4.15	-24.73-34.8%	-18.35
NPM (%)	7.14	2.79	-57.88	-41.69
EPS (Rs)	4.69+166.5%	1.76	-15.52-35.7%	-11.44
CEPS	4.69	1.76	-15.52	-11.44

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2013	Final Dividend	0.6	19 Sep 2013

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split